- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04798885
Get Going After concussioN 2.0 (GAIN2)
November 10, 2023 updated by: University of Aarhus
Interdisciplinary Intervention for Patients With Post-concussion Symptoms 3-6 Months Post-injury (GAIN 2.0). A Stepped Wedge Cluster Randomised Trial: Effect on Symptoms, Participation in Daily Activities, and Labour Market Attachment
The study tests the promising results of a previous study (GAIN 1.0) in a larger RCT (GAIN 2.0) which takes place in the municipalities of Central Denmark Region where citizens live their daily lives and whose health- and social care systems support citizens who experience persisting PCS.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
Concussion, the mildest form of traumatic brain injury, is an important public health concern.
Recent studies estimate that persistent post-concussion symptoms (PCS) are present in almost half of the affected citizens at one year post-injury.
Prospective studies have demonstrated that these citizens are at risk of developing long-lasting symptoms which are associated with high societal burden due to long-term impact on labour market attachment and increased use of health care and social benefits.
In Denmark, there has in recent years been an increasing awareness on societal impact and personal consequences of PCS.
Accordingly, clinicians as well as social workers and therapists in the municipalities point to the gab in knowledge concerning PCS and advocate urgently for evidence-based treatment for these citizens.
Recently, the research group behind this application developed a novel early intervention - "Get going After concussIoN" (GAIN 1.0) - for citizens who experience persistent PCS three to six months post-concussion.
The intervention was tested in a randomized controlled trial (RCT) with promising results.
However, it was delivered in a single hospital setting in which these citizens are normally not cared for.
In this study the intention is to test the results of GAIN 1.0 in a larger RCT (GAIN 2.0) which takes place in the municipalities of Central Denmark Region where citizens live their daily lives and whose health- and social care systems support citizens who experience persisting PCS.
Study Type
Interventional
Enrollment (Actual)
310
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Hammel, Denmark, 8450
- Regionshospitalet Hammel Neurocenter
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 58 years (Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Concussion caused by a head trauma according to the diagnostic criteria recommended by WHO. Participants must be referred to the project within two to four months of injury.
- Age 18 to 60 years at the time of the trauma
- A RPQ score ≥20.
- Able to understand, speak and read Danish.
- Living in Central Denmark Region.
Exclusion Criteria:
- Objective neurological findings and/or acute trauma CT scan indicating neurological disease or brain damage.
- Previous concussion leading to persistent PCS within the last two years.
- Severe misuse of alcohol, prescription drugs and/or illegal drugs.
- Psychiatric morbidity or severe neurological disease that impedes participation in the program, i.e. Bipolar Disorder, autism, psychotic disorder (life time), multiple sclerosis etc.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Enhanced usual care
Participants will be informed about typical Post Concussion Symptoms and the process of typical recovery as well as given reassurance concerning the prognosis.
Advice concerning the use of pain relief medication will also be provided.
|
|
Experimental: GAIN 2.0 intervention
An eight-week, interdisciplinary intervention program based on principles from cognitive behavioural therapy (CBT) and gradual return to activities.
|
1) three structured group sessions of two hours duration performed jointly by a neuropsychologist, an occupational therapist and a physiotherapist.
Relatives are also invited.
2) Up to five weekly semi-structured individual sessions of 30 min.
duration with an allocated therapist
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of at least seven in the sum score on the Rivermead Post-Concussion Symptoms Questionnaire (RPQ)
Time Frame: Three months after end of treatment
|
RPQ is a self-report scale to measure the severity of Post Concussion Symptoms covering physical, cognitive, and emotional symptoms with 16 sub-items and a total sum score (range 0-64, higher score define more severe status)
|
Three months after end of treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Sumscore in the dimension 'time spend on daily activities' on the Utrecht Scale for Evaluation of Rehabilitation-Participation (USER-P).
Time Frame: Three months after end of treatment
|
Utrecht Scale for Evaluation of Rehabilitation-Participation is a generic measurement that both objectively and subjectively measure participation in Instrumental Activities of Daily Living (IADL) such as work, voluntary work, education, family duties and responsibilities, leisure activities, transportation, communication and social activities in three dimensions.
The sumscore in each dimension is converted to a 0-100 metric with higher scores meaning af better outcome.
|
Three months after end of treatment
|
Sumscore in the dimension 'limitations' on the Utrecht Scale for Evaluation of Rehabilitation-Participation (USER-P)
Time Frame: Three months after end of treatment
|
Utrecht Scale for Evaluation of Rehabilitation-Participation is a generic measurement that both objectively and subjectively measure participation in Instrumental Activities of Daily Living (IADL) such as work, voluntary work, education, family duties and responsibilities, leisure activities, transportation, communication and social activities in three dimensions.The sumscore in each dimension is converted to a 0-100 metric with higher scores meaning af better outcome.
|
Three months after end of treatment
|
Sumscore in the dimension 'satisfaction with participation' on the Utrecht Scale for Evaluation of Rehabilitation-Participation (USER-P)
Time Frame: Three months after end of treatment
|
Utrecht Scale for Evaluation of Rehabilitation-Participation is a generic measurement that both objectively and subjectively measure participation in Instrumental Activities of Daily Living (IADL) such as work, voluntary work, education, family duties and responsibilities, leisure activities, transportation, communication and social activities in three dimensions.The sumscore in each dimension is converted to a 0-100 metric with higher scores meaning af better outcome.
|
Three months after end of treatment
|
Long term sick leave defined as public assistance benefits related to illness in more than three consecutive weeks
Time Frame: Within 12 months after concussion
|
Calculated based on weekly public assistance benefits extracted from the DREAM register
|
Within 12 months after concussion
|
Cumulated incidence proportion of participants on long term sick leave defined as receiving public assistance benefits related to illness in more than three consecutive weeks
Time Frame: Within 36 months after concussion
|
Calculated based on weekly public assistance benefits extracted from the DREAM register
|
Within 36 months after concussion
|
Proportion of employed participants defined as receiving no public assistance benefits except from state education fund grants
Time Frame: At 12 months after concussion
|
Calculated based on weekly public assistance benefits extracted from the DREAM register
|
At 12 months after concussion
|
Proportion of employed participants defined as receiving no public assistance benefits except from state education fund grants
Time Frame: At 36 months after concussion
|
Calculated based on weekly public assistance benefits extracted from the DREAM register
|
At 36 months after concussion
|
Degree of job stability based on whether labor market contributions have been paid
Time Frame: At 12 months after concussion
|
Monthly measure extracted from the DREAM register
|
At 12 months after concussion
|
Degree of job stability based on whether labor market contributions have been paid
Time Frame: At 36 months after concussion
|
Monthly measure extracted from the DREAM register
|
At 36 months after concussion
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Jørgen F Nielsen, Professor, Hammel Neurorehabilitation Centre and University clinic
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 12, 2021
Primary Completion (Actual)
June 1, 2023
Study Completion (Estimated)
September 1, 2024
Study Registration Dates
First Submitted
March 9, 2021
First Submitted That Met QC Criteria
March 12, 2021
First Posted (Actual)
March 15, 2021
Study Record Updates
Last Update Posted (Estimated)
November 13, 2023
Last Update Submitted That Met QC Criteria
November 10, 2023
Last Verified
November 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- GAIN 2.0
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mild Traumatic Brain Injury
-
Assistance Publique - Hôpitaux de ParisMinistry of Health, FranceCompleted
-
McGill University Health Centre/Research Institute...UnknownMild Traumatic Brain Injury; ConcussionCanada, France, Israel
-
ElMindA LtdGE HealthcareCompletedTBI (Traumatic Brain Injury) | Mild Traumatic Brain Injury | Concussion, MildUnited States
-
First Affiliated Hospital Xi'an Jiaotong UniversityHealth Science Center of Xi'an Jiaotong University; The Second Affiliated Hospital...RecruitingMTBI - Mild Traumatic Brain InjuryChina
-
Perception Dynamics InstituteUniversity of California, San Diego; University of South Alabama; University...RecruitingMTBI - Mild Traumatic Brain InjuryUnited States
-
Washington University School of MedicineTerminated
-
Centre Hospitalier de DouaiCompletedCompliance, Patient | Mild Brain Traumatic InjuryFrance
-
Bispebjerg HospitalUniversity of Copenhagen; Synoptik-Fonden; IT University of Copenhagen; The Danish...RecruitingBrain Concussion | mTBI - Mild Traumatic Brain InjuryDenmark
-
Children's National Research InstituteCreare, Inc.RecruitingConcussion | MTBI - Mild Traumatic Brain InjuryUnited States
-
University of CopenhagenRigshospitalet, Denmark; Sygekassernes HelsefondCompletedMild Traumatic Brain Injury | Concussion, MildDenmark
Clinical Trials on GAIN 2.0
-
Washington University School of MedicineCenters for Disease Control and Prevention; Missouri Department of Social Services... and other collaboratorsCompletedAggression | Depression | PTSD | VictimizationUnited States
-
Yale UniversityNational Cancer Institute (NCI)Completed
-
Pennington Biomedical Research CenterEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompleted
-
Indonesia UniversityRecruitingEnd Stage Renal Disease on DialysisIndonesia
-
Norwegian School of Sport SciencesCompletedPregnancy | Excessive Weight GainNorway
-
Helena PiccininiNova Scotia Health AuthorityCompleted
-
MetroHealth Medical CenterCompletedPregnancy Related | Weight Gain
-
University of MinnesotaHealthy Foods Healthy LivesCompletedObesityUnited States
-
University of GlasgowUniversity of Pisa; Göteborg UniversityCompletedObesity | Cardiovascular Disease | Diabetes | Weight Loss | Weight GainUnited Kingdom